Connect with a Global Network of Leaders Driving Microbiome Partnerships and Progress
Microbiome science continues to unlock new therapeutic potential across neurology, dermatology, gastrointestinal, and immune-related diseases. Yet translating this complexity into consistent clinical outcomes, scalable manufacturing, and commercially viable therapies remains a shared challenge across the field.
Leading companies such as Vedanta Biosciences, MRM Health and Salspera are making meaningful progress towards addressing those challenges. However, advancing microbiome therapies requires more than individual effort. It demands cross-functional collaboration between biopharma and the right solution partners.
That is exactly what the 11th Microbiome Movement USA Summit is designed to deliver. This meeting is built to foster collaboration and partnership by connecting senior microbiome decision-makers across preclinical, clinical, and manufacturing functions with solution providers who can help make therapies more commercially viable and clinically trusted.
You will engage directly with C-level executives, VPs, and Directors actively seeking CDMOs, CROs, sequencing, and analytics partners to strengthen their programs and accelerate progress.
Join Vedanta Biosciences, AOBiome, Ferring Pharmaceuticals, Kanvas Biosciences, Nestlé Health Science, and others in a focused environment where partnerships are built, challenges are tackled, and microbiome therapies move closer to patients.
What to Expect?
Own Your Position in a Microbiome Community Advancing Towards Commercialization
Connect with microbiome leaders progressing LBPs and FMTs into the clinic to build partnerships that strengthen clinical validation, regulatory confidence, and commercial readiness in a trust-sensitive field.
Stay Ahead of What Microbiome Biopharma Needs Next
Gain insight into clinical variability, mechanistic uncertainty, and CMC complexity shaping microbiome programs to position your solution where it improves reproducibility, scalability, and regulatory approval pathways.
Become the Partner Microbiome Leaders Trust at Critical Decision Points
Align your brand with teams tackling multi-strain manufacturing and preclinical and clinical strategy challenges to become the trusted partner selected to de-risk development and accelerate microbiome therapies towards regulatory approval.
Key Interest Areas
Senior microbiome leaders attending are actively looking for service and solution partners with capabilities including:
- CDMOs
- Sequencing & Analysis
- Clinical CROs
- Preclinical CROs
Hear What Our Past Sponsors Have to Say
Great to be in the same room with the teams that continue to innovate and reinvent the future of live biotherapeutics.
List Biological Laboratories, 2025
The sponsor-vendor ratio was favorable and made it easy for us to have conversations with potential customers. The on-site staff were helpful in making sure we were meeting with everyone we wanted to.
Catawba Research, 2024
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Available Inventory
We offer a range of sponsorship opportunities designed to position your brand at the heart of microbiome innovation, from thought leadership and networking to targeted engagement with decision-makers actively advancing clinical and commercial programs.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Samuel Turner
Partnerships Director
11th Microbiome Movement USA Summit
Maintain Your Competitive Edge
Position your brand alongside leading solution providers to stay visible in microbiome partnership and vendor selection discussions.
Network With Decision-Makers
Connect with C-level microbiome leaders advancing LBPs and FMTs to build relationships that lead to active partnerships.
Showcase Your Capabilities
Promote your solutions across presenting, exhibiting, and branding opportunities to align with programs seeking clinical validation and scale-up support.